annual book value:
$1.03B+$571.35M(+123.28%)Summary
- As of today (July 4, 2025), RXRX annual book value is $1.03 billion, with the most recent change of +$571.35 million (+123.28%) on December 31, 2024.
- During the last 3 years, RXRX annual book value has risen by +$491.84 million (+90.59%).
- RXRX annual book value is now at all-time high.
Performance
RXRX Book value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly book value:
$933.95M-$100.83M(-9.74%)Summary
- As of today (July 4, 2025), RXRX quarterly book value is $933.95 million, with the most recent change of -$100.83 million (-9.74%) on March 31, 2025.
- Over the past year, RXRX quarterly book value has increased by +$532.80 million (+132.82%).
- RXRX quarterly book value is now -9.74% below its all-time high of $1.03 billion, reached on December 31, 2024.
Performance
RXRX quarterly book value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Book value Formula
Book Value = Total Assets − Total Liabilities
RXRX Book value Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +123.3% | +132.8% |
| 3 y3 years | +90.6% | +89.2% |
| 5 y5 years | +932.7% | - |
RXRX Book value Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +123.3% | -9.7% | +140.7% |
| 5 y | 5-year | at high | +601.6% | -9.7% | +500.8% |
| alltime | all time | at high | +601.6% | -9.7% | +500.8% |
RXRX Book value History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $933.95M(-9.7%) |
| Dec 2024 | $1.03B(+123.3%) | $1.03B(+97.3%) |
| Sep 2024 | - | $524.56M(-10.2%) |
| Jun 2024 | - | $584.45M(+45.7%) |
| Mar 2024 | - | $401.15M(-13.4%) |
| Dec 2023 | $463.44M(-4.6%) | $463.44M(+5.8%) |
| Sep 2023 | - | $437.97M(-6.6%) |
| Jun 2023 | - | $468.96M(+9.0%) |
| Mar 2023 | - | $430.18M(-11.5%) |
| Dec 2022 | $485.81M | $485.81M(+25.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $388.03M(-11.3%) |
| Jun 2022 | - | $437.58M(-11.3%) |
| Mar 2022 | - | $493.57M(-9.1%) |
| Dec 2021 | $542.94M(-363.2%) | $542.94M(-9.4%) |
| Sep 2021 | - | $599.03M(-6.8%) |
| Jun 2021 | - | $642.71M(-375.8%) |
| Mar 2021 | - | -$233.03M(+13.0%) |
| Dec 2020 | -$206.29M(+66.0%) | - |
| Dec 2020 | - | -$206.29M |
| Dec 2019 | -$124.27M | - |
FAQ
- What is Recursion Pharmaceuticals annual book value?
- What is the all time high annual book value for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals annual book value year-on-year change?
- What is Recursion Pharmaceuticals quarterly book value?
- What is the all time high quarterly book value for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals quarterly book value year-on-year change?
What is Recursion Pharmaceuticals annual book value?
The current annual book value of RXRX is $1.03B
What is the all time high annual book value for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high annual book value is $1.03B
What is Recursion Pharmaceuticals annual book value year-on-year change?
Over the past year, RXRX annual book value has changed by +$571.35M (+123.28%)
What is Recursion Pharmaceuticals quarterly book value?
The current quarterly book value of RXRX is $933.95M
What is the all time high quarterly book value for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high quarterly book value is $1.03B
What is Recursion Pharmaceuticals quarterly book value year-on-year change?
Over the past year, RXRX quarterly book value has changed by +$532.80M (+132.82%)